SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thure Meyer who wrote (652)3/20/1998 1:31:00 PM
From: Steven Messina,L.M.T.   of 1837
 
CNBC just did a nice bit on Duramed....stock is soaring. All the investment community had to hear was that Premarin was the most widely prescribed drug in the world, and that there was no generic equivalent due to FDA claims. In order to be considered "generic", the chemical structure (including all inert ingredients) must be EXACT. The generic Duramed wants to push does not contain the "exact" inert substances, from what has been reported. The FDA, for reasons we all know, considers the inert substances as "important". Inert ingredients?.....perhaps they should grab a dictionary and look up the word.

Excellent daytrade...am all over it.

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext